Alectos Therapeutics Inc.
$10,000.00 CAD
≈ 2 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- June 11, 2018 – December 10, 2018
- Reference
- nrc-cnrc:172-2018-2019-Q1-908629
Published purpose
This project will involve assay development and characterization of novel small-molecule glucocerebrosidase inhibitor/modulator therapeutics for Parkinson’s disease.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions